Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Gilead Sciences Inc patentsThe following is a sampling of recent Gilead Sciences Inc patent applications (USPTO Patent Application #, Patent Title) sorted by month.
August 2012 - Gilead Sciences Inc patents
20120220608 - Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
20120196846 - Anti-rsv compounds
July 2012 - Gilead Sciences Inc patents
20120189538 - Use of a2a adenosine receptor agonists
20120190866 - Antiviral compounds
June 2012 - Gilead Sciences Inc patents
20120165350 - Process for preparing an a2a-adenosine receptor agonist and its polymorphs
20120156166 - Inhibitors of flaviviridae viruses
20120157404 - Antiviral compounds
May 2012 - Gilead Sciences Inc patents
20120107274 - 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
April 2012 - Gilead Sciences Inc patents
20120093890 - Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
March 2012 - Gilead Sciences Inc patents
20120065227 - Triazolopyridinone derivatives for use as stearoyl coa desaturase inhibitors
20120053148 - Inhibitors of hepatitis c virus
February 2012 - Gilead Sciences Inc patents
20120045412 - Cycloalkylidene and heterocycloalkylidene inhibitor compounds
20120046299 - Method of treating arrhythmias
20120027752 - Methods and compounds for treating paramyxoviridae virus infections
January 2012 - Gilead Sciences Inc patents
20120020921 - 1'-substituted-carba-nucleoside prodrugs for antiviral treatment
20120009147 - 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
20120010192 - Fused heterocyclic compounds as ion channel modulators
20120003215 - Pyrazolo[1,5-a]pyrimidines for antiviral treatment
20120003329 - Use of a2b adenosine receptor antagonists for treating pulmonary hypertension
20120004188 - Use of ranolazine for treating pulmonary hypertension
20120004267 - Apoptosis signal-regulating kinase inhibitors
August 2011 - Gilead Sciences Inc patents
20110196021 - High affinity nucleic acid ligands of complement system proteins
July 2011 - Gilead Sciences Inc patents
20110183990 - Method of treating atrial fibrillation
20110184002 - Method of treating hepatic disease using a2b adenosine receptor antagonists
20110178058 - Inhibitors of flaviviridae viruses
20110178129 - Inhibitors of flaviviridae viruses
20110171196 - Methods of treatment and uses for camkii and its interaction with hdacs and calpain
20110172192 - Method and compositions for treating hematological malignancies
June 2011 - Gilead Sciences Inc patents
20110160162 - Prodrugs of a2b adenosine receptor antagonists
20110160458 - Process and intermediates for preparing integrase inhibitors
20110150836 - Methods of treating hbv and hcv infection
20110144050 - Salts of hiv inhibitor compounds
20110135599 - Antiviral compounds
20110135604 - Antiviral compounds
20110130362 - A2b adenosine receptor antagonists
20110130559 - Methods to manufacture 1,3-dioxolane nucleosides
May 2011 - Gilead Sciences Inc patents
20110123493 - 2,4,6-trisubstituted pyrido(3,2-d) pyrimidines useful for treating viral infections
20110124589 - Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
20110124627 - Modulators of toll-like receptors
April 2011 - Gilead Sciences Inc patents
20110098248 - Modulators of toll-like receptors
20110081314 - Antiviral phosphinate compounds
20110082112 - Antiviral phosphinate compounds
March 2011 - Gilead Sciences Inc patents
20110070194 - 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
20110052527 - Imidazopyridinyl thiazolyl histone deacetylase inhibitors
January 2011 - Gilead Sciences Inc patents
20110020278 - Inhibitors of flaviviridae viruses
20110009410 - Apoptosis signal-regulating kinase inhibitors
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Gilead Sciences Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gilead Sciences Inc with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support - Terms & Conditions
|
REGISTER now for FREE 
